<DOC>
	<DOCNO>NCT01647451</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial evaluate change disease activity follow intravenous ( i.v . ) administration two dose NNC0114-0006 compare placebo subject active rheumatoid arthritis ( RA ) background methotrexate ( MTX ) therapy .</brief_summary>
	<brief_title>A Randomised , Double-blind , Placebo-controlled , Parallel-group Trial Assess Clinical Efficacy NNC0114-0006 Subjects With Active Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<criteria>A diagnosis RA meeting 2010 ACR ( American College Rheumatology ) classification criterion , obtain least 6 month prior dose trial product . ( If diagnosis make prior 2010 , diagnosis meeting 1987 ACR classification criterion acceptable ) Active RA characterise DAS28CRP ( disease activity score base 28 joint creactive protein ) equal 4.5 least five tender five swollen joint ( joint ) 28 joint count Concomitant treatment MTX equal 15 mg/week least 4 month prior screen , stable dose equal 15 mg/week 25 mg/week least 6 week prior screen ( MTX dose 7.5 12.5 mg/week allow , patient intolerance 15 mg/week ) Biologic naïve subject subject treat biologics RA ( biologic experience ) provide meet one follow criterion : . Reason discontinuation biologic therapy intolerance ( e.g. , unable receive recommend dos achieve adequate treatment duration drug relate side effect ) , b . Discontinued biologic therapy reason lack efficacy ( primary secondary failure ) intolerance ( e.g. , drug holiday ) Body mass index ( BMI ) equal 18.0 equal 38.0 kg/m^2 Subjects rheumatic autoimmune disease RA , significant systemic involvement secondary RA ( include limit vasculitis , pulmonary fibrosis , Felty 's syndrome ) . Subjects secondary Sjögren 's syndrome stable hypothyroidism eligible Any active ongoing bacterial infection within 4 week prior randomisation , unless treat resolved appropriate therapy ( e.g. , simple urinary tract infection ) Any history recurrent infection condition predispose chronic infection ( e.g. , bronchiectasis , chronic osteomyelitis ) History severe systemic fungal infection within past 12 month prior screen unless treat resolved appropriate therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>